Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "69b943971630191889750e09",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Lithium Carbonate IP 450 mg",
"description": "Lithium Carbonate IP 450 mg for Mood Stabilization and Mental Wellness\n\nMental health plays a vital role in overall well-being, and conditions like bipolar disorder and mood instability require consistent and effective management. ELCARBONATE 450 SR, containing Lithium Carbonate IP 450 mg, is a well-established medication widely used in psychiatry for stabilizing mood and preventing extreme emotional swings.\n\nThis sustained-release (SR) formulation ensures gradual absorption, providing long-lasting therapeutic effects with improved patient compliance. Let’s explore in detail how this medication works, its uses, benefits, side effects, and important precautions.\n\nProduct Overview\n\nELCARBONATE 450 SR is a prescription medication formulated with Lithium Carbonate IP 450 mg, primarily used for the treatment and prevention of mood disorders such as bipolar disorder. Lithium has been used for decades and is considered one of the most effective mood stabilizers.\n\nThe sustained-release property helps maintain steady levels of lithium in the blood, reducing the risk of sudden fluctuations and side effects.\n\nHow ELCARBONATE 450 SR Works\n\nLithium works by affecting the levels of certain chemicals (neurotransmitters) in the brain, which are responsible for mood regulation.\n\nMechanism of Action\n\nBalances Neurotransmitters:\nLithium helps regulate serotonin and dopamine levels, improving mood stability.\n\nStabilizes Brain Activity:\nIt reduces abnormal electrical activity in the brain that can lead to manic episodes.\n\nProtects Nerve Cells:\nLithium has neuroprotective properties, helping to preserve brain function over time.\n\nControls Mood Swings:\nIt prevents both extreme highs (mania) and lows (depression), making it effective for long-term management.\n\nUses of Lithium Carbonate IP 450 mg (ELCARBONATE 450 SR)\n\nELCARBONATE 450 SR is prescribed for:\n\nBipolar Disorder:\nControls manic and depressive episodes.\n\nMania Treatment:\nReduces symptoms like hyperactivity, irritability, and rapid thoughts.\n\nMood Stabilization:\nMaintains emotional balance over time.\n\nPrevention of Recurrence:\nHelps prevent future episodes of mania and depression.\n\nAdjunct Therapy in Depression:\nSometimes used along with antidepressants for better results.\n\nKey Benefits of ELCARBONATE 450 SR\n1. Effective Mood Stabilization\n\nLithium is considered the gold standard for managing bipolar disorder and mood swings.\n\n2. Long-Lasting Action\n\nThe sustained-release formulation provides consistent therapeutic effects throughout the day.\n\n3. Reduces Risk of Relapse\n\nRegular use helps prevent recurring episodes of mania and depression.\n\n4. Improves Quality of Life\n\nPatients experience better emotional control and improved daily functioning.\n\n5. Neuroprotective Effects\n\nHelps protect brain cells and supports long-term mental health.\n\n6. Proven Clinical Effectiveness\n\nLithium has decades of clinical evidence supporting its safety and efficacy.\n\nDosage and Administration\n\nTake ELCARBONATE 450 SR exactly as prescribed by your doctor\n\nUsually taken once or twice daily\n\nSwallow the tablet whole; do not crush or chew\n\nMaintain adequate fluid intake\n\nImportant Note:\n\nRegular blood tests are required to monitor lithium levels and avoid toxicity.\n\nSide Effects of ELCARBONATE 450 SR\n\nLike all medications, this product may cause side effects. These vary from mild to serious depending on dosage and individual response.\n\nCommon Side Effects\n\nNausea\n\nMild tremors\n\nIncreased thirst\n\nFrequent urination\n\nWeight gain\n\nDrowsiness\n\nDry mouth\n\nThese are usually manageable and may decrease over time.\n\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nSevere tremors or muscle weakness\n\nConfusion or difficulty concentrating\n\nSlurred speech\n\nIrregular heartbeat\n\nSevere diarrhea or vomiting\n\nSigns of lithium toxicity (blurred vision, dizziness, coordination issues)\n\nPrecautions & Warnings\n\nBefore using ELCARBONATE 450 SR, consider the following:\n\n1. Regular Monitoring\n\nLithium levels must be checked periodically to avoid toxicity.\n\n2. Hydration is Essential\n\nDehydration can increase lithium levels and lead to side effects.\n\n3. Kidney and Thyroid Function\n\nPatients with kidney or thyroid disorders should use this medication cautiously.\n\n4. Pregnancy & Breastfeeding\n\nConsult a doctor before use, as lithium may affect the fetus or infant.\n\n5. Drug Interactions\n\nAvoid combining with certain medications like diuretics or NSAIDs without medical advice.\n\nWho Should Avoid This Medication?\n\nPatients with severe kidney disease\n\nIndividuals with sodium imbalance\n\nThose allergic to lithium\n\nPatients with untreated thyroid conditions\n\nTips for Safe Use\n\nTake the medicine at the same time every day\n\nDo not skip doses\n\nAvoid sudden discontinuation\n\nMaintain a balanced diet with consistent salt intake\n\nInform your doctor about all medications you are taking\n\nWhy Choose ELCARBONATE 450 SR?\n\nTrusted lithium formulation\n\nSustained-release technology for better control\n\nClinically proven effectiveness\n\nHelps maintain stable mental health\n\nSupports long-term treatment plans\n\nConclusion\nELCARBONATE 450 SR (Lithium Carbonate IP 450 mg) is a highly effective and reliable medication for managing bipolar disorder and mood instability. With its sustained-release formulation, it provides consistent therapeutic benefits, helping individuals maintain emotional balance and improve their quality of life.",
"price": 182.0,
"discountamount": 55.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2337,
"imageuri": "https://productimages.withfloats.com/actual/69b9439e6779b672d8ff7d42.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69b9439e6779b672d8ff7d42.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-03-17T12:05:43.634Z",
"updatedon": "2026-05-09T06:34:42.757Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/lithium-carbonate-ip-450-mg/2337",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ELCARBONATE 450 SR",
"category": "NEUROLOGYRANGE",
"tags": [
"lithium carbonate tablets uses and dosage",
"lithium carbonate for bipolar disorder treatment",
"lithium carbonate side effects and precautions",
"lithium carbonate extended release tablets india",
"lithium carbonate 300 mg tablets benefits",
"lithium carbonate tablets for mood stabilizationlithium",
"medicine for bipolar disorder mood swings",
"tablets for mania and mental health stabilization",
"psychiatric medicine for long term mood control",
"what is lithium carbonate used for",
"lithium carbonate mechanism of action explained",
"lithium carbonate drug interactions list",
"lithium carbonate tablets supplier in india",
"lithium carbonate manufacturer india pharma",
"lithium carbonate bulk supplier india",
"lithium carbonate tablets price in india",
"lithium carbonate extended release tablets price",
"best treatment for bipolar disorder in india",
"lithium carbonate dosage for bipolar disorder"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6958c5905a7ae6137dc2c613",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "iguratimod 25 mg",
"description": "Introduction\n\nLiving with chronic joint pain, stiffness, and inflammation can quietly affect every part of daily life—from simple movements like walking and gripping objects to maintaining an active professional and social routine. Autoimmune conditions such as rheumatoid arthritis often progress slowly but steadily, making early and effective treatment essential for long-term joint health and quality of life.\n\nIBRUNITIME 25, containing Iguratimod 25 mg, is a disease-modifying antirheumatic drug (DMARD) developed to address the root cause of inflammatory joint diseases rather than merely masking symptoms. Unlike conventional painkillers that offer temporary relief, IBRUNITIME 25 works at the immune system level to reduce inflammation, slow joint damage, and improve overall physical function.\n\nThis medication is widely prescribed as part of long-term management strategies for inflammatory arthritis, particularly rheumatoid arthritis, helping patients regain mobility, reduce pain, and protect joint structure over time.\n\nComposition\n\nActive Ingredient: Iguratimod 25 mg\n\nBrand Name: IBRUNITIME 25\n\nDosage Form: Oral Tablet\n\nIguratimod is known for its immunomodulatory and anti-inflammatory properties, making it a valuable option in modern rheumatology care.\n\nHow IBRUNITIME 25 Works\n\nIguratimod works differently from standard anti-inflammatory medicines. Instead of only reducing pain signals, it directly influences immune system activity that leads to chronic inflammation.\n\nKey mechanisms include:\n\nSuppression of inflammatory cytokines such as interleukin-6 (IL-6)\n\nReduction of autoantibody production\n\nInhibition of processes that cause joint cartilage and bone damage\n\nBy targeting these underlying mechanisms, IBRUNITIME 25 helps slow disease progression and preserves joint integrity over time.\n\nUses of IBRUNITIME 25\n1. Rheumatoid Arthritis (RA)\n\nThe primary use of IBRUNITIME 25 is in the treatment of rheumatoid arthritis, a chronic autoimmune disorder characterized by joint pain, swelling, stiffness, and progressive joint destruction.\n\n2. Inflammatory Joint Disorders\n\nIBRUNITIME 25 may also be prescribed in other inflammatory joint conditions where immune-mediated inflammation plays a significant role.\n\n3. Combination Therapy\n\nIt is often used alongside other DMARDs such as methotrexate, depending on disease severity and patient response, to enhance treatment outcomes.\n\nKey Benefits of IBRUNITIME 25\n1. Reduces Joint Pain and Swelling\n\nRegular use helps significantly decrease pain, tenderness, and swelling in affected joints, making daily activities more manageable.\n\n2. Improves Joint Mobility\n\nBy controlling inflammation, IBRUNITIME 25 improves flexibility and range of motion, allowing patients to move more comfortably.\n\n3. Slows Disease Progression\n\nUnlike pain relievers, this medication helps slow the progression of rheumatoid arthritis and reduces long-term joint damage.\n\n4. Targets the Root Cause\n\nIBRUNITIME 25 works on immune pathways responsible for chronic inflammation, offering more comprehensive disease control.\n\n5. Enhances Quality of Life\n\nWith better pain control, improved mobility, and reduced stiffness, patients often experience improved physical independence and emotional well-being.\n\n6. Suitable for Long-Term Use\n\nWhen taken under medical supervision, it is designed for long-term disease management rather than short-term symptom relief.\n\nDosage and Administration\n\nThe usual recommended dose is Iguratimod 25 mg, taken once or twice daily, as prescribed by a healthcare professional.\n\nTablets should be swallowed whole with water.\n\nIt can be taken with or after food to minimize stomach discomfort.\n\nDosage duration depends on disease severity, response to treatment, and physician guidance.\n\nImportant: Do not adjust the dose or stop the medication without consulting your doctor, even if symptoms improve.\n\nPossible Side Effects of IBRUNITIME 25\n\nLike all medications, IBRUNITIME 25 may cause side effects, although not everyone experiences them. Most side effects are mild to moderate and manageable with proper medical supervision.\n\nCommon Side Effects\n\nMild stomach discomfort\n\nNausea\n\nDiarrhea\n\nDizziness\n\nHeadache\n\nLess Common Side Effects\n\nElevated liver enzymes\n\nFatigue\n\nSkin rash\n\nLoss of appetite\n\nRare but Serious Side Effects\n\nLiver function abnormalities\n\nSevere allergic reactions\n\nSignificant gastrointestinal issues\n\nPatients are usually advised to undergo periodic blood tests to monitor liver function and overall health during treatment.\n\nPrecautions and Warnings\n\nLiver Health: Patients with existing liver disorders should use IBRUNITIME 25 cautiously and only under medical supervision.\n\nPregnancy and Breastfeeding: Not recommended unless clearly advised by a doctor.\n\nAlcohol Consumption: Excessive alcohol intake should be avoided due to potential liver strain.\n\nInfections: Inform your doctor if you have active or recurrent infections, as immune modulation may affect infection resistance.\n\nDrug Interactions: Always disclose current medications, supplements, or herbal products to your healthcare provider.\n\nWho Should Avoid IBRUNITIME 25?\n\nIndividuals with severe liver disease\n\nPatients with known hypersensitivity to Iguratimod\n\nPregnant or breastfeeding women (unless specifically prescribed)\n\nStorage Instructions\n\nStore at room temperature\n\nKeep away from moisture and direct sunlight\n\nKeep out of reach of children\n\nDo not use after the expiry date\n\nConclusion\n\nIBRUNITIME 25 (Iguratimod 25 mg) represents a modern, targeted approach to managing rheumatoid arthritis and chronic inflammatory joint disorders. By addressing the immune-driven causes of inflammation rather than simply relieving pain, it offers long-term benefits such as reduced joint damage, improved mobility, and enhanced quality of life.\n\nWhen used responsibly under medical supervision, IBRUNITIME 25 can become an essential part of a comprehensive arthritis management plan—helping patients move with confidence, reduce daily discomfort, and regain control over their health journey.\n\nIf you or your patients are seeking a dependable disease-modifying therapy that balances effectiveness with tolerability, IBRUNITIME 25 stands as a reliable and clinically valuable option in rheumatology care.",
"price": 308.0,
"discountamount": 93.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2260,
"imageuri": "https://productimages.withfloats.com/actual/6958c5977b11f839cdd4d298.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6958c5977b11f839cdd4d298.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-01-03T07:30:24.617Z",
"updatedon": "2026-05-16T09:01:15.85Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//iguratimod-25-mg/2260",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "IBRUNITIME 25",
"category": "ORTHOLOGYRANG",
"tags": [
"Iguratimod 25 mg Tablets",
"Buy Iguratimod 25 mg Tablets Online",
"Anti-Rheumatic Medicine Iguratimod 25 mg",
"Iguratimod 25 mg DMARD Tablets",
"Best Iguratimod Tablets for Rheumatoid Arthritis Treatment",
"Iguratimod 25 mg Tablets for Autoimmune Joint Disorders",
"Disease Modifying Anti-Rheumatic Drug Iguratimod",
"Buy Iguratimod Tablets Online",
"Iguratimod Tablets for Chronic Joint Inflammation",
"Iguratimod 25 mg Tablets for Arthritis Management",
"Advanced Rheumatology Medicine Iguratimod 25 mg",
"iguratimod 25 mg",
"tab iguratimod 25 mg",
"iguratimod 25 mg tablet uses",
"iguratimod 25 mg price",
"iguratimod 25 mg side effects",
"iguratimod 25 mg tab",
"iguratimod 25 mg side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6954d5cbb4697f18294b1c0e",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Dydrogesterone 10 mg",
"description": "DABROSTON 10 is a pharmaceutical preparation containing Dydrogesterone 10 mg, a synthetic progestogen that closely mimics the natural hormone progesterone produced by the female body. Manufactured with precision and care, DABROSTON 10 represents a breakthrough in women's reproductive health management, offering a reliable and effective solution for various gynecological conditions related to progesterone deficiency.\nUnlike many other synthetic progestogens, Dydrogesterone in DABROSTON 10 has a unique molecular structure that allows it to work specifically on the uterine lining without causing unwanted androgenic or estrogenic effects. This makes it an ideal choice for women requiring hormonal support while minimizing the risk of side effects commonly associated with other progestational agents.\nDABROSTON 10 is prescribed by healthcare professionals worldwide for conditions ranging from menstrual irregularities to fertility support, endometriosis management, and prevention of miscarriage in women with a history of recurrent pregnancy loss. Its versatility and safety profile have made it a cornerstone in modern gynecological therapeutics.\nUnderstanding Dydrogesterone and Its Uses\nDydrogesterone is an orally active progestogen that was specifically developed to provide the benefits of natural progesterone without the drawbacks of traditional synthetic progestogens. When you take DABROSTON 10, the Dydrogesterone is absorbed into your bloodstream and acts on progesterone receptors throughout your body, particularly in the uterus, where it exerts its primary therapeutic effects.\nPrimary Uses of DABROSTON 10:\nMenstrual Disorders: DABROSTON 10 is highly effective in treating various menstrual irregularities, including dysmenorrhea (painful periods), irregular menstrual cycles, and secondary amenorrhea (absence of periods). By regulating the endometrial lining, it helps restore normal menstrual patterns and reduces associated discomfort.\nEndometriosis Management: For women suffering from endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, causing pain and fertility issues, DABROSTON 10 helps suppress the growth of endometrial tissue and provides significant symptom relief.\nLuteal Phase Support: During fertility treatments or for women with luteal phase defects, DABROSTON 10 provides crucial progesterone support to help prepare the uterine lining for embryo implantation and maintain early pregnancy.\nPrevention of Miscarriage: Women with a history of recurrent miscarriage due to progesterone deficiency can benefit from DABROSTON 10, which helps maintain the uterine environment necessary for pregnancy continuation.\nPremenstrual Syndrome (PMS): The hormonal imbalances that contribute to PMS symptoms can be effectively managed with DABROSTON 10, providing relief from mood swings, breast tenderness, and bloating.\nHormone Replacement Therapy (HRT): When combined with estrogen therapy in postmenopausal women, DABROSTON 10 protects the uterine lining from excessive growth (endometrial hyperplasia) that estrogen alone might cause.\nDysfunctional Uterine Bleeding: Abnormal uterine bleeding not caused by organic pathology can be controlled with DABROSTON 10 by regulating the endometrial cycle.\nKey Benefits of DABROSTON 10\n1. Natural Hormone Profile\nOne of the most significant advantages of DABROSTON 10 is its molecular similarity to natural progesterone. This means your body recognizes and processes it almost identically to the progesterone it produces naturally, resulting in better tolerance and effectiveness.\n2. Minimal Side Effects\nUnlike many synthetic progestogens that can cause masculinizing effects, weight gain, or mood disturbances, DABROSTON 10 has a remarkably clean side effect profile. It doesn't possess androgenic, estrogenic, or glucocorticoid activity, which means fewer unwanted effects on your body.\n3. Selective Progestational Activity\nDABROSTON 10 works specifically on the uterine lining where it's needed most, without significantly affecting other body systems. This targeted action makes it highly effective for gynecological conditions while maintaining safety.\n4. Oral Administration\nThe convenience of oral dosing makes DABROSTON 10 easy to incorporate into your daily routine. No injections or invasive procedures are required, and the tablets can be taken with or without food.\n5. Pregnancy Safe\nWhen prescribed appropriately, DABROSTON 10 is considered safe during pregnancy, particularly in the first trimester for women at risk of miscarriage. It doesn't harm fetal development and can be crucial in maintaining healthy pregnancies.\n6. Metabolic Neutrality\nDABROSTON 10 doesn't adversely affect lipid metabolism, glucose tolerance, or blood clotting factors in the way some other hormonal preparations might. This makes it suitable for a broader range of women, including those with metabolic concerns.\n7. Flexible Dosing\nThe 10 mg strength allows for flexible dosing regimens tailored to individual needs. Your healthcare provider can adjust the timing and duration of treatment based on your specific condition and response.\n8. Proven Efficacy\nDecades of clinical use and extensive research have established DABROSTON 10 (Dydrogesterone) as a gold standard in progestogen therapy. Its effectiveness has been demonstrated in numerous clinical trials and real-world applications.\n9. Quality of Life Improvement\nBy effectively managing hormonal imbalances and their associated symptoms, DABROSTON 10 significantly improves quality of life. Women report better sleep, improved mood, reduced pain, and enhanced overall well-being.\n10. Supports Fertility Goals\nFor women trying to conceive, DABROSTON 10 provides essential hormonal support that can make the difference between conception success and failure, particularly in cases of luteal phase deficiency or recurrent pregnancy loss.\nUnderstanding Side Effects\nWhile DABROSTON 10 is generally well-tolerated, like all medications, it may cause side effects in some individuals. Understanding these potential effects helps you make informed decisions and know when to contact your healthcare provider.\nCommon and Generally Mild Side Effects:\nHeadache: Some women experience mild to moderate headaches, particularly when first starting treatment. These typically resolve as your body adjusts to the medication.\nNausea: Mild nausea may occur, especially if taken on an empty stomach. Taking DABROSTON 10 with food can help minimize this effect.\nBreast Tenderness: Temporary breast sensitivity or tenderness is relatively common and usually subsides with continued use.\nMood Changes: Mild mood fluctuations may occur, though DABROSTON 10 is less likely to cause mood disturbances compared to other progestogens.\nDizziness: Some women report feeling slightly dizzy, particularly shortly after taking the medication.\nAbdominal Discomfort: Mild stomach discomfort or bloating may occur but is generally temporary.\nLess Common Side Effects:\nBreakthrough bleeding or spotting between periods may occur, especially during the first few cycles of treatment. Fatigue or drowsiness can affect some individuals. Skin reactions such as mild rash or itching are possible but rare. Some women may experience changes in menstrual flow pattern. Rarely, liver function changes may occur, which is why periodic monitoring may be recommended for long-term use.\nWhen to Contact Your Healthcare Provider:\nWhile serious side effects are rare with DABROSTON 10, you should contact your doctor immediately if you experience severe abdominal pain, significant mood changes or depression, jaundice (yellowing of skin or eyes), severe allergic reactions including difficulty breathing or swelling, severe or persistent headaches, visual disturbances, or unusual vaginal bleeding.\nIt's important to remember that most women taking DABROSTON 10 experience few to no side effects. The benefits of treatment typically far outweigh the potential risks, especially when the medication is used as prescribed under medical supervision.\nImportant Considerations\nNot for Everyone: DABROSTON 10 should not be used by women with known hypersensitivity to Dydrogesterone, undiagnosed vaginal bleeding, or certain liver conditions. Always inform your healthcare provider about your complete medical history.\nDrug Interactions: Certain medications may interact with DABROSTON 10, including some enzyme-inducing drugs that can reduce its effectiveness. Inform your doctor about all medications, supplements, and herbal products you're taking.\nPregnancy and Breastfeeding: While DABROSTON 10 is used to support early pregnancy, its use in later pregnancy stages should only be under medical supervision. Small amounts may pass into breast milk, so discuss with your doctor if you're breastfeeding.\nMonitoring: Depending on your condition and duration of treatment, your healthcare provider may recommend periodic check-ups and possibly liver function tests to ensure safe, continued use.\nHow to Use DABROSTON 10\nAlways take DABROSTON 10 exactly as prescribed by your healthcare provider. The dosing regimen varies depending on the condition being treated. It may be taken continuously, cyclically (certain days of your menstrual cycle), or in specific patterns for fertility support. Tablets should be swallowed whole with water and can be taken with or without food. If you miss a dose, take it as soon as you remember unless it's nearly time for your next dose. Never double up doses to make up for a missed one.\nConclusion\nDABROSTON 10 represents a significant advancement in women's reproductive health management, offering a safe, effective, and well-tolerated solution for various gynecological conditions related to progesterone deficiency. Its unique molecular structure, which closely mimics natural progesterone, sets it apart from other synthetic progestogens by providing therapeutic benefits without the unwanted androgenic effects commonly associated with hormonal treatments.",
"price": 637.0,
"discountamount": 191.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2258,
"imageuri": "https://productimages.withfloats.com/actual/6954d5cd5542d9b6b39275fa.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/6954d5cd5542d9b6b39275fa.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-31T07:50:35.025Z",
"updatedon": "2026-03-12T11:33:06.791Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dydrogesterone-10-mg/2258",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "DABROSTON 10",
"category": "GYANECOLOGYRANGE",
"tags": [
"Dydrogesterone 10 mg",
"Menstrual Disorders.",
"Prevention of Miscarriage.",
"Premenstrual Syndrome (PMS).",
"endometrial tissue proliferation outside the uterus.",
"Endometriosis Management.",
"hormonal treatments.",
"dydrogesterone 10 mg.",
"dydrogesterone 10 mg tablet uses.",
"dydrogesterone 10 mg tablet uses in hindi",
"dydrogesterone 10 mg tablet uses in pregnancy.",
"tablet dydrogesterone 10 mg.",
"dydrogesterone 10 mg in pregnancy.",
"dydrogesterone 10 mg tablet price."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69299814dd213181136f04b2",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Rosuvastatin and Clopidogrel Capsules",
"description": "Rosuvastatin and Clopidogrel Capsules is a potent combination medication designed to manage and prevent cardiovascular diseases by targeting two critical factors: cholesterol levels and blood clot formation. This combination is particularly recommended for patients at high risk of heart attacks, strokes, or those with existing cardiovascular conditions. By integrating the lipid-lowering benefits of rosuvastatin with the antiplatelet action of clopidogrel, these capsules provide a dual mechanism of action aimed at improving cardiovascular health and reducing potentially life-threatening events.\n\nUses:\nRosuvastatin and Clopidogrel Capsules are primarily used for:\n\nControlling high cholesterol levels, especially reducing low-density lipoprotein (LDL) and triglycerides while increasing high-density lipoprotein (HDL).\n\nPreventing blood clot formation (thrombosis) by inhibiting platelet aggregation, which significantly lowers the risk of heart attacks and strokes.\n\nSlowing the progression of atherosclerosis (plaque buildup in arteries), helping to maintain open blood vessels for improved blood flow.\n\nManaging conditions like coronary artery disease, peripheral artery disease, and after procedures such as angioplasty or bypass surgery to reduce recurrent cardiovascular events.\n\nKey Benefits:\n\nCombined efficacy in lowering cholesterol and preventing clot-related complications contributes to reduced cardiovascular morbidity and mortality.\n\nImproved blood flow achieved by preventing arterial blockages and promoting vascular health.\n\nStabilization of cholesterol plaques in arteries, reducing their risk of rupture.\n\nProtection against acute coronary syndromes and ischemic stroke.\n\nEnhances long-term cardiovascular outcomes in high-risk patients through a synergistic effect of both drugs.\nConvenient oral capsule form encourages patient adherence to prescribed regimens.\nSide Effects:\nWhile generally well tolerated, Rosuvastatin and Clopidogrel Capsules may cause side effects. Common side effects include headache, dizziness, gastrointestinal disturbances such as nausea or abdominal pain, and muscle aches. Patients might experience fatigue or weakness occasionally.\n\nSerious side effects are less frequent but require immediate medical attention. These include severe muscle pain or tenderness (a sign of rhabdomyolysis), allergic reactions, unusual bleeding or bruising (due to clopidogrel’s blood-thinning effects), liver dysfunction, and signs of an infection such as fever or chills. Regular monitoring of liver function tests, blood counts, and muscle-related symptoms is essential during therapy.\n\nConclusion:\nRosuvastatin and Clopidogrel Capsules serve as a comprehensive therapeutic approach for patients with cardiovascular diseases by simultaneously addressing two major risk factors: elevated cholesterol and thrombus formation. Their combined use reduces the risk of heart attacks, strokes, and other severe cardiovascular events while promoting healthier blood flow and vascular function. Adherence to prescribed dosages and periodic medical evaluations will maximize the benefits while minimizing side effect risks. Always consult healthcare professionals before starting or stopping therapy to ensure safety and effectiveness.",
"price": 173.0,
"discountamount": 52.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2223,
"imageuri": "https://productimages.withfloats.com/actual/6929981653223ab539492563.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6929981653223ab539492563.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-28T12:39:48.689Z",
"updatedon": "2026-03-14T08:11:22.327Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//rosuvastatin-and-clopidogrel-capsules/2223",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ROUSTRIN CV 10",
"category": "cardiology",
"tags": [
"Rosuvastatin and Clopidogrel Capsules",
"cardiovascular diseases",
"heart attacks",
"cardiovascular conditions",
"heart attacks strokes.",
"clopidogrel.",
"cholesterol levels and blood clot formation.",
"Rosuvastatin and Clopidogrel Capsules."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "668e8611b9f7300708fe1240",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRIOGLIMITERIS 1/0.2 ",
"description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n",
"price": 195.0,
"discountamount": 58.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"500 mg",
"0.2 mg",
"one tablet",
"Weight gain",
"Glimepiride 1",
"metformin use",
"Proper dosage",
"Glimepiride (1",
"dosage regimen",
"typical dosage",
"renal function",
"insulin release",
"drug metabolism",
"Lactic acidosis",
"Close monitoring",
"dose adjustments",
"renal impairment",
"diabetic patients",
"insulin secretion",
"different aspects",
"Drug Interactions",
"other medications",
"Regular monitoring",
"Dosage adjustments",
"Allergic reactions",
"peripheral tissues",
"hepatic metabolism",
"glucose metabolism",
"insulin sensitivity",
"healthcare provider",
"Hepatic dysfunction",
"Common side effects",
"abdominal discomfort",
"different mechanisms",
"liver function tests",
"diabetic ketoacidosis",
"pancreatic beta cells",
"combination medication",
"carbohydrate digestion",
"comprehensive approach",
"serious adverse effect",
"Metformin Hydrochloride",
"carbohydrate absorption",
"sulfonylurea derivative",
"glucose-dependent manner",
"optimal glycemic control",
"type 1 diabetes mellitus",
"type 2 diabetes mellitus",
"More severe side effects",
"alpha-glucosidase enzymes",
"peripheral glucose uptake",
"hepatic glucose production",
"alpha-glucosidase inhibitor",
"individual patient response",
"personalized treatment plans",
"optimal therapeutic outcomes",
"Gastrointestinal disturbances",
"intestinal glucose absorption",
"other antidiabetic medications",
"other oral antidiabetic agents",
"postprandial blood glucose levels",
"other significant medical conditions"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1939,
"imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-07-10T13:01:05.875Z",
"updatedon": "2026-03-26T05:46:52.891Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//trioglimiteris-1-0-2-/1939",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TRIOGLIMITERIS 1/0.2 ",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride 1mg+metformin 500mg+voglibose 0.2 mg",
"Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b",
"glimepiride 2mg+metformin 500mg+voglibose 0.2 mg",
"voglibose glimepiride & metformin hydrochloride (s",
"voglibose glimepiride + metformin hydrochloride us",
"glimepiride 1mg+metformin 500mg+voglibose 0.3 mg",
"glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g",
""
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6662e74687f0960e14a2d95a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Gefitinib 250mg",
"description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n",
"price": 2760.0,
"discountamount": 828.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"food",
"Call",
"Uses",
"Rash",
"Note",
"NSCLC",
"Email",
"nausea",
"Dosage",
"spread",
"WhatsApp",
"diarrhea",
"Gefitinib",
"treatment",
"One tablet",
"GEFISTERIS",
"information",
"sterispharma",
"consultation",
"sterisonline",
"Side Effects",
"cancer cells",
"targeted therapy",
"Regular monitoring",
"healthcare provider",
"small cell lung cancer",
"healthcare professional",
"specific EGFR mutations",
"epidermal growth factor receptor",
"potential liver function alterations"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1530,
"imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T10:56:06.808Z",
"updatedon": "2026-04-15T10:04:00.767Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GEFISTERIS 250",
"category": "Oncology",
"tags": [
"gefitinib 250 mg uses",
"gefitinib 250 mg online purchase",
"gefitinib 250 mg tablets price in india",
"non-small cell lung cancer (NSCLC).",
"triggered by chemotherapy.",
"cancer biology.",
"Superior Efficacy in EGFR-Mutant NSCLC",
"gefitinib 250mg",
"gefitinib 250mg tablet",
"gefitinib 250mg tab",
"gefitinib 250 mg tablet uses in lung cancer",
"gefitinib tablets 250 mg dosage and benefits",
"gefitinib 250 mg price in india",
"gefitinib 250 mg EGFR inhibitor for NSCLC treatment india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6661a73687f0960e14a2c739",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "mycophenolate sodium 360 mg",
"description": "MYCOPLASM S 360 \nMycophenolate sodium 360 mg is an essential immunosuppressant medication designed to prevent organ transplant rejection, particularly for kidney, heart, and liver transplants. As the sodium salt of mycophenolic acid, it delivers 360 mg of the active moiety per tablet, providing targeted immune suppression to help patients maintain their new organs long-term. This product stands out for its enteric-coated formulation, which enhances gastrointestinal tolerability compared to other forms, making it a preferred choice in post-transplant care regimens.\n\nUses of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg primarily serves as a prophylactic agent against acute rejection in adult and pediatric patients receiving allogeneic renal, cardiac, or hepatic transplants. It works alongside other immunosuppressants like cyclosporine and corticosteroids to create a balanced regimen that minimizes the risk of graft loss. Clinically, it proves effective in de novo transplant recipients, where starting therapy early post-surgery significantly reduces rejection episodes. Beyond transplants, off-label applications include managing refractory autoimmune conditions such as lupus nephritis or myasthenia gravis, where immune overactivity damages tissues.\n\nThe drug targets the proliferation of T- and B-lymphocytes, key players in immune responses that can attack transplanted organs. In renal transplant patients, for instance, it helps preserve kidney function by curbing antibody-mediated rejection. Its role extends to maintenance therapy, where consistent dosing sustains immunosuppression without excessive toxicity. Healthcare providers often adjust it based on patient response and trough levels of the active metabolite, mycophenolic acid (MPA), ensuring optimal therapeutic outcomes.\n\nKey Benefits of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg offers several advantages that make it a cornerstone in transplant medicine. One primary benefit is its selective inhibition of lymphocyte proliferation, sparing other cell types and reducing broad-spectrum immunosuppression risks. This leads to fewer opportunistic infections compared to older agents like azathioprine. The enteric coating minimizes upper GI upset, improving patient compliance—studies show higher adherence rates with this formulation.\n\nEnhanced Graft Survival: Prolongs organ viability by effectively suppressing cell-mediated and humoral immunity, with clinical data showing reduced biopsy-proven rejection rates.\n\nImproved Tolerability: Lower incidence of nausea and diarrhea due to delayed-release technology, allowing twice-daily dosing without food restrictions.\n\nFlexible Dosing: Equivalent to 720 mg mycophenolate mofetil, but with predictable MPA exposure via enterohepatic recirculation for steady-state efficacy.\n\nPediatric Suitability: Approved for children over 2 years in renal transplants, supporting growth without compromising safety.\n\nCost-Effective Long-Term Option: Balances efficacy and side effect profile, potentially lowering overall healthcare costs from fewer rejections or hospitalizations.\n\nPatients experience better quality of life, with sustained energy levels and fewer interruptions from acute rejection crises. Its metabolism to MPA via liver glucuronidation ensures reliable pharmacokinetics, even in patients with mild renal impairment.\n\nSide Effects of Mycophenolate Sodium 360 mg\nWhile highly effective, mycophenolate sodium 360 mg carries risks typical of immunosuppressants, necessitating vigilant monitoring. Common adverse effects stem from its impact on rapidly dividing cells, particularly in the gut and bone marrow.\n\nCommon Side Effects\nGastrointestinal issues like diarrhea, nausea, vomiting, and abdominal pain, affecting up to 30-50% of users.\n\nHeadache, insomnia, and tremor, often mild and transient.\n\nInfections such as urinary tract or respiratory, due to moderated immunity.\n\nHypertension or peripheral edema, manageable with supportive care.\n\nLeukopenia or anemia, requiring periodic blood counts.\n\nSerious Side Effects\nSevere myelosuppression leading to neutropenia or thrombocytopenia, which can increase infection or bleeding risks.\n\nProgressive multifocal leukoencephalopathy (PML), a rare brain infection linked to JC virus reactivation.\n\nGastrointestinal perforation or bleeding, especially in at-risk patients.\n\nIncreased malignancy risk, including lymphoma or skin cancers, over long-term use.\n\nHypersensitivity reactions like rash or anaphylaxis.\n\nRegular complete blood counts, viral monitoring (e.g., CMV, BK virus), and skin exams mitigate these risks. Dose reductions or discontinuation may be needed if counts drop significantly.\n\nMechanism of Action\nMycophenolate sodium 360 mg rapidly hydrolyzes to mycophenolic acid (MPA), a potent, reversible, non-competitive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). This enzyme catalyzes the rate-limiting step in de novo guanine nucleotide synthesis, depleting guanosine nucleotides essential for T- and B-cell DNA replication. Lymphocytes, reliant on this pathway, undergo proliferation arrest, suppressing both cell-mediated immunity and antibody production.\n\nMPA also hinders glycosylation of adhesion molecules on lymphocytes and monocytes, impeding their migration to graft sites. It reduces nitric oxide production in macrophages without affecting endothelial cells, curbing inflammation. Enterohepatic recirculation of the glucuronide metabolite (MPAG) prolongs MPA exposure, enhancing efficacy. Protein binding to albumin (around 97%) ensures targeted delivery, with clearance primarily renal for the inactive form.\n\nDosage and Administration Guidelines\nStandard dosing for renal transplant is 720 mg (two 360 mg tablets) twice daily, starting within 72 hours post-surgery. Adjustments occur for hepatic or cardiac transplants, often alongside cyclosporine. Therapeutic drug monitoring of MPA AUC (area under curve) optimizes levels between 30-60 mcg·h/mL. Take on an empty stomach for best absorption, though food has minimal impact due to the coating.\n\nPrecautions and Warnings\nAvoid in pregnancy (Category D) due to teratogenicity—use contraception and regular pregnancy tests. Contraindicated in active untreated infections. Monitor for GI bleeding in ulcerative colitis patients. Drug interactions with antacids, cholestyramine, or rifampin alter MPA levels. Live vaccines are prohibited.\n\nConclusion\nMycophenolate sodium 360 mg represents a vital advancement in transplant immunosuppression, offering robust protection against rejection with a favorable benefit-risk profile. Its targeted action on lymphocytes, combined with improved GI tolerance, empowers patients to thrive post-transplant. By integrating it into comprehensive regimens with close monitoring, healthcare teams maximize graft success and patient well-being. Always consult a specialist for personalized guidance to harness its full potential safely.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-s-360-133670\n\n\n\n\n\n\n",
"price": 767.0,
"discountamount": 567.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"dose",
"risk",
"body",
"part",
"ORDER",
"360mg",
"Email",
"cells",
"dosage",
"nausea",
"vomiting",
"schedule",
"headache",
"strength",
"WhatsApp",
"diarrhea",
"activity",
"rejection",
"treatment",
"infections",
"supplements",
"information",
"MYCOPLASM S",
"sterispharma",
"sterisonline",
"stomach pain",
"blood counts",
"immune system",
"complications",
"liver problems",
"liver function",
"other medications",
"Regular monitoring",
"medical conditions",
"healthcare provider",
"Common side effects",
"Serious side effects",
"white blood cell count",
"potential drug interactions",
"optimal therapeutic effects",
"combination therapy regimen",
"organ transplant recipients",
"Mycophenolate Sodium therapy",
"other immunosuppressive drugs"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1474,
"imageuri": "https://productimages.withfloats.com/actual/6661a739c749b7962dbc08c6.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/6661a739c749b7962dbc08c6.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-06T12:10:30.488Z",
"updatedon": "2026-03-12T08:02:36.733Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mycophenolate-sodium-360-mg/1474",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MYCOPLASM S 360 ",
"category": "Oncology",
"tags": [
"MYCOPLASM S 360",
"Mycophenolate sodium (360mg)",
"Mycophenolate sodium 360 mg price",
"Mycophenolate sodium 360 mg brands",
"Mycophenolate sodium 360 mg side effects",
"Myfortic 360 alternative",
"Myfortic 500"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "665dbc2a161afa2274ff131d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "metolazone 5mg",
"description": "METALONIX 5 is a prescription medication containing Metolazone 5 mg, a powerful diuretic commonly referred to as a “water pill.” It is widely used in the medical field to help manage conditions related to fluid retention (edema) and high blood pressure (hypertension). By promoting the elimination of excess salt and water from the body through urine, METALONIX 5 helps reduce swelling, improves cardiovascular function, and supports overall health.\n\nMetolazone belongs to a class of medications known as thiazide-like diuretics. These medicines act on the kidneys, specifically the distal tubules, to prevent the reabsorption of sodium and chloride. As a result, excess fluid is removed from the bloodstream and tissues. METALONIX 5 is often prescribed when other diuretics alone are not sufficient, especially in patients with heart, kidney, or liver-related fluid accumulation.\n\nThis medication should always be used under the supervision of a qualified healthcare professional to ensure safe and effective treatment.\n\nComposition\n\nActive Ingredient: Metolazone 5 mg\n\nDosage Form: Oral tablet\n\nBrand Name: METALONIX 5\n\nEach tablet of METALONIX 5 is carefully formulated to deliver a consistent dose of Metolazone, ensuring reliable therapeutic effects.\n\nHow METALONIX 5 Works\n\nMETALONIX 5 works by increasing urine production through its action on the kidneys. Metolazone blocks the reabsorption of sodium and chloride in the kidney’s distal tubule. This process causes water to follow the salt out of the body, leading to increased urine output.\n\nBy removing excess fluid, METALONIX 5 helps:\n\nReduce swelling in the legs, ankles, and abdomen\n\nLower blood pressure\n\nDecrease the workload on the heart\n\nImprove breathing in patients with fluid buildup in the lungs\n\nBecause of its potent diuretic effect, METALONIX 5 is frequently used in combination with other diuretics in patients with severe fluid retention.\n\nUses of METALONIX 5\n\nMETALONIX 5 is prescribed for several medical conditions associated with fluid accumulation and cardiovascular stress. Some of its primary uses include:\n\n1. Treatment of Edema (Fluid Retention)\n\nEdema is a condition in which excess fluid accumulates in body tissues, causing swelling. METALONIX 5 helps eliminate the extra fluid and provides relief from symptoms such as puffiness, weight gain, and discomfort.\n\nCommon conditions causing edema include:\n\nCongestive heart failure\n\nKidney disease\n\nLiver disorders such as cirrhosis\n\nCertain medications that cause fluid retention\n\n2. Management of High Blood Pressure\n\nMETALONIX 5 can be used to help control hypertension. By reducing the volume of fluid in the bloodstream, the medication lowers pressure on the walls of blood vessels. Maintaining healthy blood pressure levels reduces the risk of serious complications such as:\n\nHeart attack\n\nStroke\n\nKidney damage\n\n3. Supportive Treatment in Heart Failure\n\nPatients with congestive heart failure often develop fluid buildup in the lungs and limbs. METALONIX 5 helps remove this fluid, making breathing easier and reducing strain on the heart.\n\n4. Kidney Disease Management\n\nIn individuals with chronic kidney conditions, fluid retention is common. METALONIX 5 helps regulate fluid balance and supports better kidney function by promoting urine production.\n\nKey Benefits of METALONIX 5\n\nMETALONIX 5 offers several important therapeutic benefits for patients suffering from fluid-related conditions.\n\nEffective Fluid Removal\n\nOne of the main advantages of METALONIX 5 is its strong diuretic action. It efficiently removes excess water and sodium from the body, providing rapid relief from swelling.\n\nImproved Cardiovascular Health\n\nBy lowering blood pressure and reducing fluid overload, METALONIX 5 supports better heart health and helps prevent cardiovascular complications.\n\nEnhanced Breathing\n\nPatients experiencing fluid buildup in the lungs often report improved breathing after using METALONIX 5, as the medication reduces pulmonary congestion.\n\nComplementary Therapy\n\nMETALONIX 5 can be used in combination with other diuretics or blood pressure medications to enhance treatment effectiveness.\n\nReduced Swelling and Discomfort\n\nSwelling in the legs, ankles, and abdomen can be painful and restrictive. METALONIX 5 helps relieve these symptoms, allowing patients to move more comfortably.\n\nRecommended Usage and Dosage\n\nMETALONIX 5 should be taken exactly as prescribed by a healthcare professional. The dosage may vary depending on the patient’s condition, age, and response to treatment.\n\nGeneral guidelines include:\n\nTake the tablet orally with water.\n\nIt is usually taken once daily.\n\nDoctors may adjust the dose based on medical needs.\n\nTaking the medication earlier in the day is often recommended to prevent nighttime urination.\n\nPatients should never exceed the prescribed dosage without medical advice.\n\nPossible Side Effects of METALONIX 5\n\nWhile METALONIX 5 is effective for treating fluid retention and hypertension, some individuals may experience side effects. Most side effects are mild and manageable, but medical attention should be sought if they persist.\n\nCommon Side Effects\n\nIncreased urination\n\nDizziness or lightheadedness\n\nHeadache\n\nFatigue\n\nMild stomach discomfort\n\nElectrolyte Imbalance\n\nBecause METALONIX 5 removes fluids and minerals from the body, it may lead to electrolyte imbalances such as:\n\nLow potassium levels\n\nLow sodium levels\n\nMuscle cramps\n\nWeakness\n\nDoctors may recommend periodic blood tests to monitor electrolyte levels.\n\nLess Common Side Effects\n\nNausea or vomiting\n\nDry mouth\n\nSkin rash\n\nChanges in blood sugar levels\n\nSerious Side Effects (Rare)\n\nIn rare cases, patients may experience more severe reactions such as:\n\nSevere dehydration\n\nIrregular heartbeat\n\nSevere allergic reactions\n\nKidney function changes\n\nIf any serious symptoms occur, immediate medical attention is necessary.\n\nPrecautions and Safety Information\n\nBefore taking METALONIX 5, patients should inform their healthcare provider about their medical history and any medications they are currently using.\n\nImportant precautions include:\n\nInform the doctor if you have kidney or liver disease.\n\nPatients with gout or diabetes should use this medication carefully.\n\nAvoid excessive dehydration while taking this medicine.\n\nPregnant or breastfeeding women should consult their doctor before use.\n\nRegular monitoring of blood pressure and electrolyte levels is recommended.\n\nAlcohol consumption may increase the risk of dizziness while taking this medication.\n\nStorage Instructions\n\nTo maintain the effectiveness of METALONIX 5:\n\nStore at room temperature.\n\nKeep away from direct sunlight and moisture.\n\nKeep out of reach of children.\n\nDo not use after the expiration date.\nConclusion\nMETALONIX 5 (Metolazone 5 mg) is a highly effective diuretic medication designed to treat conditions related to fluid retention and high blood pressure. By promoting the removal of excess salt and water from the body, it helps reduce swelling, improve heart function, and support better overall health.\n\nThis medication is particularly beneficial for patients with congestive heart failure, kidney disease, liver disorders, and hypertension. When used under proper medical supervision, METALONIX 5 can significantly improve quality of life by relieving symptoms associated with fluid overload.",
"price": 216.0,
"discountamount": 65.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"Call",
"Email",
"ORDER",
"WhatsApp",
"METALONIX",
"Metolazone",
"information",
"sterispharma",
"sterisonline"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1254,
"imageuri": "https://productimages.withfloats.com/actual/665dbc326e6ad0d07a21ae33.png",
"tileimageuri": "https://productimages.withfloats.com/tile/665dbc326e6ad0d07a21ae33.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-03T12:50:50.231Z",
"updatedon": "2026-03-13T11:38:35.146Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//metolazone-5mg/1254",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METALONIX 5",
"category": "CARDIOLOGYRANGE",
"tags": [
"metolazone 5mg tablet uses for swelling",
"metolazone 5mg diuretic tablet uses",
"metolazone 5mg dosage for edema",
"metolazone 5mg dosage for hypertension",
"metolazone 5mg fluid retention medicine",
"buy metolazone 5mg tablets online",
"metolazone 5mg price in india",
"order metolazone 5mg tablets online",
"metolazone 5mg generic tablets buy",
"best price metolazone 5mg tablets",
"metolazone 5mg tablet for fluid overload",
"how to take metolazone 5mg tablets",
"metolazone 5mg tablet for hypertension treatment",
"metolazone 5mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6634c4a9ae1cfd0bbc282281",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "BOSENTIME 125",
"description": "BOSENTIME 125\nBosentan (125mg)\n\"Bosentime 125\" is a medication containing Bosentan in a strength of 125mg. Bosentan is a type of medication known as an endothelin receptor antagonist. It works by blocking the action of endothelin, a substance in the body that narrows blood vessels and increases blood pressure. Here are key points about Bosentime 125:\n\nPurpose: Bosentime 125 is primarily used to treat pulmonary arterial hypertension (PAH). PAH is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart.\nDosage: The usual recommended dose of Bosentime 125 for adults with PAH is 125mg twice daily, taken orally. It is important to follow your doctor's instructions regarding dosage and frequency.\nAdministration: Bosentime 125 tablets should be taken with food to improve absorption. Swallow the tablets whole with water and do not crush or chew them.\nEffectiveness: Bosentan helps to relax and widen the blood vessels in the lungs, which reduces the workload on the heart and improves exercise capacity in individuals with PAH.\nMonitoring: Regular monitoring of liver function is necessary while taking Bosentime 125, as it can affect liver enzymes. Your doctor may perform blood tests to check liver function periodically.\nSide Effects: Common side effects of Bosentime 125 may include headache, flushing, nasal congestion, and liver function abnormalities. It is essential to report any unusual symptoms to your healthcare provider.\nPrecautions: Bosentan can cause birth defects if taken during pregnancy. It is important to use effective contraception while taking this medication and to avoid pregnancy. Inform your doctor if you are pregnant or planning a pregnancy.\nInteractions: Bosentan may interact with certain medications, including hormonal contraceptives, cyclosporine, and certain HIV medications. Inform your doctor about all medications you are taking before starting Bosentime 125.\nStorage: Store Bosentime 125 tablets at room temperature away from moisture and heat. Keep them out of reach of children and pets.\nConsultation: Always consult your doctor or healthcare provider for personalized advice and guidance regarding the use of Bosentime 125, including dosage adjustments and potential drug interactions.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n",
"price": 1351.0,
"discountamount": 405.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"use",
"pets",
"heat",
"food",
"dose",
"type",
"body",
"lungs",
"heart",
"125mg",
"water",
"reach",
"adults",
"doctor",
"Storage",
"Purpose",
"arteries",
"guidance",
"strength",
"moisture",
"children",
"Bosentan",
"headache",
"flushing",
"workload",
"frequency",
"substance",
"pregnancy",
"key points",
"absorption",
"right side",
"individuals",
"blood tests",
"Precautions",
"cyclosporine",
"Consultation",
"instructions",
"Effectiveness",
"liver enzymes",
"blood vessels",
"birth defects",
"Administration",
"PAH. Monitoring",
"HIV medications",
"room temperature",
"unusual symptoms",
"nasal congestion",
"exercise capacity",
"dosage adjustments",
"Regular monitoring",
"Common side effects",
"personalized advice",
"high blood pressure",
"healthcare provider",
"Bosentime 125 tablets",
"hormonal contraceptives",
"effective contraception",
"potential drug interactions",
"liver function abnormalities",
"endothelin receptor antagonist",
"pulmonary arterial hypertension"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1056,
"imageuri": "https://productimages.withfloats.com/actual/6634c5040b2293f75b95bb15.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6634c5040b2293f75b95bb15.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-05-03T11:04:09.715Z",
"updatedon": "2026-03-13T08:48:55.346Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//bosentime-125/1056",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Bosentan (125mg)",
"category": "ORTHOLOGYRANG",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}